Cargando…

Dual Anticoagulation With Warfarin and Apixaban: A Case Report

We report the case of a female with recurrent venous thromboembolisms (VTEs) despite being appropriately anticoagulated. Different anticoagulants were trialed and all led to treatment failure. As a result, the patient was started on dual anticoagulation with warfarin and apixaban. There were no recu...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Kristen, Yonosko, Paula, Pilkington, Deon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556604/
https://www.ncbi.nlm.nih.gov/pubmed/36249603
http://dx.doi.org/10.7759/cureus.29093
_version_ 1784807099510816768
author Parker, Kristen
Yonosko, Paula
Pilkington, Deon
author_facet Parker, Kristen
Yonosko, Paula
Pilkington, Deon
author_sort Parker, Kristen
collection PubMed
description We report the case of a female with recurrent venous thromboembolisms (VTEs) despite being appropriately anticoagulated. Different anticoagulants were trialed and all led to treatment failure. As a result, the patient was started on dual anticoagulation with warfarin and apixaban. There were no recurrences of clots while the patient was adherent to dual anticoagulation. This case report adds to current literature demonstrating the efficacy of dual anticoagulation in patients with recurrent VTE who fail single-agent therapy. It also demonstrates the need for additional studies that evaluate the utility of dual anticoagulants as a treatment modality for patients failing monotherapy.
format Online
Article
Text
id pubmed-9556604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-95566042022-10-15 Dual Anticoagulation With Warfarin and Apixaban: A Case Report Parker, Kristen Yonosko, Paula Pilkington, Deon Cureus Hematology We report the case of a female with recurrent venous thromboembolisms (VTEs) despite being appropriately anticoagulated. Different anticoagulants were trialed and all led to treatment failure. As a result, the patient was started on dual anticoagulation with warfarin and apixaban. There were no recurrences of clots while the patient was adherent to dual anticoagulation. This case report adds to current literature demonstrating the efficacy of dual anticoagulation in patients with recurrent VTE who fail single-agent therapy. It also demonstrates the need for additional studies that evaluate the utility of dual anticoagulants as a treatment modality for patients failing monotherapy. Cureus 2022-09-12 /pmc/articles/PMC9556604/ /pubmed/36249603 http://dx.doi.org/10.7759/cureus.29093 Text en Copyright © 2022, Parker et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Hematology
Parker, Kristen
Yonosko, Paula
Pilkington, Deon
Dual Anticoagulation With Warfarin and Apixaban: A Case Report
title Dual Anticoagulation With Warfarin and Apixaban: A Case Report
title_full Dual Anticoagulation With Warfarin and Apixaban: A Case Report
title_fullStr Dual Anticoagulation With Warfarin and Apixaban: A Case Report
title_full_unstemmed Dual Anticoagulation With Warfarin and Apixaban: A Case Report
title_short Dual Anticoagulation With Warfarin and Apixaban: A Case Report
title_sort dual anticoagulation with warfarin and apixaban: a case report
topic Hematology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556604/
https://www.ncbi.nlm.nih.gov/pubmed/36249603
http://dx.doi.org/10.7759/cureus.29093
work_keys_str_mv AT parkerkristen dualanticoagulationwithwarfarinandapixabanacasereport
AT yonoskopaula dualanticoagulationwithwarfarinandapixabanacasereport
AT pilkingtondeon dualanticoagulationwithwarfarinandapixabanacasereport